Form 8-K - Current report:
SEC Accession No. 0001193125-20-305568
Filing Date
2020-11-30
Accepted
2020-11-30 16:05:58
Documents
12
Period of Report
2020-11-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d14863d8k.htm   iXBRL 8-K 25236
  Complete submission text file 0001193125-20-305568.txt   147417

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20201129.xsd EX-101.SCH 3081
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20201129_lab.xml EX-101.LAB 18138
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20201129_pre.xml EX-101.PRE 11415
5 EXTRACTED XBRL INSTANCE DOCUMENT d14863d8k_htm.xml XML 3409
Mailing Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362
Business Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 201358214
SIC: 2834 Pharmaceutical Preparations